2025-22763Proposed Rule

DEA Bans Designer Xanax Knockoff With Ridiculous Name

Published Date: 12/15/2025

Proposed Rule

Summary

Starting December 15, 2025, bromazolam—a drug similar to some strong sedatives—will be temporarily placed in Schedule I, meaning it’s considered very risky and illegal to make, sell, or use without special permission. This affects anyone who handles bromazolam, including makers, sellers, researchers, and users, who will now face strict rules and penalties. The move aims to keep people safe by controlling this drug quickly while the government studies it more.

Analyzed Economic Effects

4 provisions identified: 0 benefits, 4 costs, 0 mixed.

Bromazolam moved to Schedule I

The Drug Enforcement Administration intends to temporarily place bromazolam in Schedule I. When the temporary order is published, persons who handle bromazolam — including manufacture, distribution, import, export, or possession — will be subject to the regulatory controls and administrative, civil, and criminal sanctions that apply to Schedule I substances.

Researchers and labs face Schedule I rules

Researchers, laboratories, and instructors who engage in research, instructional activities, or chemical analysis of bromazolam will be subject to Schedule I regulatory controls and the same administrative, civil, and criminal sanctions. This change takes effect when the temporary scheduling order is published (the order will not be issued before January 14, 2026).

Temporary listing lasts two years (±1 year)

The temporary Schedule I placement will take effect on the date the temporary scheduling order is published in the Federal Register (the order will not be issued before January 14, 2026). The temporary placement will remain in effect for two years and may be extended for one additional year if regular scheduling proceedings are initiated.

Temporary orders not subject to judicial review

Temporary scheduling orders under 21 U.S.C. 811(h) are not subject to judicial review. That means affected parties cannot immediately seek court review of the temporary placement of bromazolam while the order is in effect.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
12/15/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in